How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy-a GIMEMA MPN WP survey

Affiliations

• ¹ Institute of Hematology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy. francesca.palandri@unibo.it.
• ² GIMEMA Data Center, Fondazione GIMEMA Franco Mandelli Onlus, Rome, Italy.
• ³ Department of Radiological and Hematological Sciences, Section of Hematology, Catholic University and Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy.
• ⁴ Department of Precision and Translational Medicine, Sapienza University, Rome, Italy.
• ⁵ Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
• ⁶ Division of Hematology, Foundation IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.
• ⁷ Division of Hematology, Azienda Ospedaliera 'Bianchi Melacrino Morelli', Reggio Calabria, Italy.
• ⁸ Hematology Unit, Department "PROMISE", University of Palermo, Palermo, Italy.
• ⁹ Department of Emergency and Organ Transplantation (D.E.T.O.), Hematology Section, University of Bari, Bari, Italy.
• ¹⁰ Division of Hematology, Department of Medicine and Surgery, Ospedale di Circolo, ASST Sette Laghi, University of Insubria, Varese, Italy.
• ¹¹ CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, University of Florence, Florence, Italy.